In Vitro Interaction of the HIV Protease Inhibitor Ritonavir with Herbal Constituents: Changes in P-gp and CYP3A4 Activity
Authors:
- Balasubrahmanyam BuddhaBBBalasubrahmanyam Buddha
- Surajit DeySDSurajit Dey
- Dhananjay PalDPDhananjay Pal
- Ashim K MitraAMAshim K Mitra
- 1 January 2004
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 11 (4) , 262-277
Abstract
The purpose of this study was to evaluate in vitro interactions of commercially obtained pure herbal constituents with p-glycoprotein P-gp and cytochrome P-450 3A4 (CYP3A4) activities, which can further modulate the transcellular transport and metabolism kinetics of orally administered drugs. Caco-2 cells grown in the presence of 0.25 μmol/L 1α,25-dihydroxy vitamin D3 and multidrug-resistant 1 (MDR1) transfected MDCK cells were used as models to evaluate the effect of purified herbal constituents (quercetin, hypericin, hyperforin from St. John’s wort, kaempferol from ginseng, silibinin from milk thistle, and allicin from garlic) on P-gp–mediated efflux of the human immunodeficiency virus (HIV) protease inhibitor ritonavir. In addition, the inhibitory effect of these constituents on CYP3A4-mediated metabolism was determined by using cortisol as a model compound. Silibinin and hyperforin did not significantly alter cellular uptake of 3H-ritonavir in Caco-2 cells. A similar result was also observed for silibinin when tested in MDR1-MDCK cells. Quercetin, hypericin, and kaempferol exhibited a remarkable inhibition of P-gp–mediated efflux of ritonavir by increasing its cellular uptake in these models. These values were also comparable with the inhibitory effect of quinidine in Caco-2 cells, a well-known inhibitor of P-gp, on ritonavir efflux from Caco-2 cells. Allicin exhibited a concentration-dependent inhibition of ritonavir efflux when tested on MDR1-MDCK cells. There was a significant decrease in the Apical to Basal/Basal to Apical (AP-BL/BL-AP) transport ratio of ritonavir in presence of hypericin, kaempferol, and quercetin. These herbal constituents inhibited the CYP3A4 activity when tested with the Vivid CYP3A4 assay kit, whereas silibinin did not alter cortisol metabolism. Hypericin showed a significant inhibition in reduced nicotinamide adenine dinucleotide phosphate (NADPH)–dependent metabolism of cortisol with 64.6% of intact drug at the end of a 1-hour study. Similarly, kaempferol and quercetin also caused substantial inhibition of cortisol metabolism with 89.7% and 90.1% of intact cortisol, respectively, compared with 45.9% in the control. Prolonged exposure of quercetin resulted in significant increase of mRNA expression of both MDR1 and CYP3A4 levels in Caco-2 cells. However, hyperforin caused upregulation of CYP3A4 and downregulation of MDR1, whereas the effect of silibinin and kaempferol remained inconclusive on these gene expressions. Hypericin, kaempferol, quercetin, and allicin inhibit the efflux and CYP3A4-mediated metabolism of xenobiotics in vitro. Hence, this study warns against the use of herbal constituents along with prescribed HIV protease inhibitors that are substrates for P-gp and/or CYP3A4.Keywords
This publication has 37 references indexed in Scilit:
- Pharmacokinetic interactions between herbal remedies and medicinal drugsXenobiotica, 2002
- Long-Term Trends in the Use of Complementary and Alternative Medical Therapies in the United StatesAnnals of Internal Medicine, 2001
- Complementary and Alternative Medicine—An Annals SeriesAnnals of Internal Medicine, 2001
- Use of Complementary and Alternative Therapies in HIV-Infected PatientsAIDS Patient Care and STDs, 2001
- Herb-drug interactions: potentially important but woefully under-researchedEuropean Journal of Clinical Pharmacology, 2000
- The Effect of Ritonavir on the Pharmacokinetics of Meperidine and NormeperidinePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Indinavir concentrations and St John's wortThe Lancet, 2000
- Unsafe and potentially safe herbal therapiesAmerican Journal of Health-System Pharmacy, 1999
- Harmless Herbs? A Review of the Recent LiteratureThe American Journal of Medicine, 1998
- Complementary AIDS therapies: the good, the bad and the uglyInternational Journal of STD & AIDS, 1997